Aprameya Engineering Ltd vs Kms Medisurgi Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aprameya Engineering Ltd is ₹ 89.9 as of 23 Oct 15:30 . The P/E Ratio of Aprameya Engineering Ltd is 12.1 as of March 2025 .The P/E Ratio of KMS Medisurgi Ltd is 0 as of March 2025 . The Market Cap of Aprameya Engineering Ltd is ₹ 194.97 crore as of March 2025 .The Market Cap of KMS Medisurgi Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Aprameya Engineering Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of KMS Medisurgi Ltd changed from 13.75 % on March 2021 to 6.6 % on March 2026 . This represents a CAGR of -11.51% over 6 years .

About Aprameya Engineering Ltd

Aprameya Engineering Limited was originally formed as a partnership firm in the name and style of 'M/s.
Aprameya Engineering' pursuant to a Deed of Partnership dated September 05, 2003, registered as on August 13, 2004 at Ahmedabad.
Subsequently, Company incorporated pursuant to a Certificate of Incorporation dated December 28, 2021 issued by the Registrar of Companies, following the conversion of Partnership Firm 'M/s.
Aprameya Engineering' to a Private Limited Company.
Further, Company converted into a Public Limited Company and its name was changed from 'Aprameya Engineering Private Limited' to 'Aprameya Engineering Limited' vide a fresh Certificate of Incorporation upon conversion dated May 12, 2022, issued by the Registrar of Companies, Ahmedabad. Company is a trusted partner in India's healthcare infrastructure space, with over two decades of experience in delivering turnkey hospital projects and integrated medical technology solutions across public and private sectors.

About KMS Medisurgi Ltd

KMS Medisurgi Limited was incorporated as 'KMS Medisurgi Private Limited' on March 25, 1999 at Mumbai.
The Company converted into a Public Limited Company and name was changed to 'KMS Medisurgi Limited' on June 15, 2016. The Company manufactures & undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive.
It is engaged in the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy Equipments, Blood Banking Equipments and other such Surgical Equipments in India. The Company was established in 1999 as surgical equipment company and since then has been launching new concepts which helped the Indian Healthcare industry.

FAQs for the comparison of Aprameya Engineering Ltd and KMS Medisurgi Ltd

Which company has a larger market capitalization, Aprameya Engineering Ltd or KMS Medisurgi Ltd?

Market cap of Aprameya Engineering Ltd is 171 Cr while Market cap of KMS Medisurgi Ltd is 43 Cr

What are the key factors driving the stock performance of Aprameya Engineering Ltd and KMS Medisurgi Ltd?

The stock performance of Aprameya Engineering Ltd and KMS Medisurgi Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aprameya Engineering Ltd and KMS Medisurgi Ltd?

As of October 24, 2026, the Aprameya Engineering Ltd stock price is INR ₹89.9. On the other hand, KMS Medisurgi Ltd stock price is INR ₹132.8.

How do dividend payouts of Aprameya Engineering Ltd and KMS Medisurgi Ltd compare?

To compare the dividend payouts of Aprameya Engineering Ltd and KMS Medisurgi Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.